Last reviewed · How we verify
NCT05676346: DAO-LUTS
Genetic DAO Deficiency and Lower Urinary Tract Symptoms
trial testing LUTS in Lower Urinary Tract Symptoms in 100 participants. Completed in 24 January 2023.
24 January 2023
Quick facts
| Lead sponsor | Complexo Hospitalario Universitario de A Coruña |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 11 October 2022 |
| Primary completion | 24 January 2023 |
| Estimated completion | 24 January 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- LUTS
Conditions studied
- Lower Urinary Tract Symptoms — all drugs for Lower Urinary Tract Symptoms →
- Histamine Intolerance — all drugs for Histamine Intolerance →
Sponsor
Complexo Hospitalario Universitario de A Coruña
Who can join
18 and older, any sex, with Lower Urinary Tract Symptoms or Histamine Intolerance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determinate the prevalence os genetic DAO deficiency in patients with lower urinary tract symptoms.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Lower Urinary Tract Symptoms (LUTS) as a New Clinical Presentation of Histamine Intolerance: A Prevalence Study of Genetic Diamine Oxidase Deficiency.
Ponce Díaz-Reixa J, Aller Rodríguez M, Martínez Breijo S, Suanzes Hernández J, et al · · 2023 · cited 6× · PMID 37959335 · DOI 10.3390/jcm12216870
Verify or expand the search:
- PubMed search for NCT05676346
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lower Urinary Tract Symptoms
Currently open trials in the same condition.
- NCT06481436 — Use of Artificial Intelligence by Urogynecologic Patients · NA · active not recruiting
- NCT06351683 — Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome · Phase 2 · recruiting
- NCT06225479 — PRescription Exercise for Older Men With Urinary Disease · NA · recruiting
- NCT06179654 — Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of th · NA · recruiting
- NCT06070675 — Comparison of a Paper and Automated Bladder Diary in Pediatric Patients · NA · recruiting
Other Complexo Hospitalario Universitario de A Coruña trials
Trials by the same sponsor.
- NCT07270523 — Therapeutic Monitoring of Beta-lactams in Critically Ill Patients With Sepsis · NA · not yet recruiting
- NCT04305860 — Acceptance of Different Thickeners in Dysphagia · NA · completed
- NCT04027088 — Effect of Preoperative Immunonutrition in Upper Digestive Tract · NA · unknown
- NCT03669692 — Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinar · NA · withdrawn
- NCT04352049 — Assessment Through Transcutaneous Brain Oximetry (NIRS) of Two Preoxygenation Techniques · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05676346 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Complexo Hospitalario Universitario de A Coruña
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05676346.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing